|
gptkbp:instanceOf
|
gptkb:Corticosteroid
|
|
gptkbp:administeredBy
|
oral
inhalation
topical application
nasal spray
|
|
gptkbp:approvedBy
|
1972
|
|
gptkbp:ATCCode
|
R03BA01
|
|
gptkbp:bioavailability
|
low (inhaled)
|
|
gptkbp:brand
|
Beclovent
Beconase
Qvar
Vanceril
|
|
gptkbp:CASNumber
|
4419-39-0
|
|
gptkbp:chemicalClass
|
corticosteroid ester
|
|
gptkbp:contraindication
|
hypersensitivity
|
|
gptkbp:developedBy
|
GlaxoSmithKline
|
|
gptkbp:discoveredIn
|
gptkb:United_Kingdom
|
|
gptkbp:eliminatedIn
|
urine
|
|
gptkbp:eliminationHalfLife
|
0.5 hours
|
|
gptkbp:hasMolecularFormula
|
C22H29ClO5
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
beclometasone
|
|
gptkbp:KEGGID
|
D07554
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:MeSH_ID
|
D002001
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:proteinBinding
|
87%
|
|
gptkbp:PubChem_CID
|
CHEMBL1200698
441336
DB00394
|
|
gptkbp:riskFactor
|
gptkb:cataracts
immunosuppression
glaucoma
growth suppression in children
|
|
gptkbp:sideEffect
|
gptkb:oral_candidiasis
headache
cough
hoarseness
throat irritation
adrenal suppression
|
|
gptkbp:synonym
|
beclomethasone
|
|
gptkbp:UNII
|
7S5I7G3JQL
|
|
gptkbp:usedFor
|
gptkb:eczema
asthma
psoriasis
chronic obstructive pulmonary disease
dermatitis
allergic rhinitis
|
|
gptkbp:bfsParent
|
gptkb:Easyhaler
gptkb:eformoterol
|
|
gptkbp:bfsLayer
|
7
|